ABVX Abivax SA American

P/E --
Forward P/E --
Price/Sales 2010.21
Beta -0.226
Div Yield --
Market Cap --

Company Analysis

Latest News

Baker Bros. Advisors exits its position in clinical-stage biotech Abivax

In a quarterly filing that reflects its portfolio as of June 30, 2026, prominent life sciences investor Baker Bros. Advisors disclosed it had completely sold...